A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma (Q33412684)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma |
scientific article |
Statements
1 reference
A phase 2 trial of lenalidomide, bortezomib, and dexamethasone in patients with relapsed and relapsed/refractory myeloma (English)
1 reference
Sagar Lonial
1 reference
Kenneth C Anderson
1 reference
Paul G Richardson
1 reference
Robert Knight
1 reference
Nikhil C Munshi
1 reference
Irene M Ghobrial
1 reference
Noopur S Raje
1 reference
Teru Hideshima
1 reference
Amitabha Mazumder
1 reference
Constantine S Mitsiades
1 reference
Robert L Schlossman
1 reference
Sundar Jagannath
1 reference
Melissa Alsina
1 reference
Dixie-Lee Esseltine
1 reference
Dixil Francis
1 reference
Wanling Xie
1 reference
David H Vesole
1 reference
Kathleen Colson
1 reference
Michelle E Maglio
1 reference
Jonathan L Kaufman
1 reference
Andrzej Jakubowiak
1 reference
Mary McKenney
1 reference
Laura E Lunde
1 reference
John Feather
1 reference
Diane Warren
1 reference
Edie Weller
1 reference
15 January 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference